Elekta has acquired assets from its Croatian distributor, a move the company says will improve support services and expand access to advanced radiation therapy technologies across the region.

The Stockholm-based oncology technology firm will establish a new office in Zagreb and bring on local staff, including service engineers and a country manager, to support its operations. The acquisition marks a shift from indirect to direct operations in Croatia, aligning with Elekta’s broader European strategy.

“Elekta’s enhanced presence in Croatia will significantly improve service support for our customers, ensuring timely maintenance and upgrades, and [leading] to more opportunities to deliver advanced radiation therapy solutions to other hospitals and clinics in the country,” said Arnaud Delhaye, Elekta’s executive vice president, region Europe. “We expect this direct presence to positively impact patient care by providing access to the best cancer treatment technologies available.”
The expansion comes as Croatia works to address gaps in its radiotherapy infrastructure. According to the country's National Cancer Plan, Croatia has 3.5 linear accelerators per million residents, below the European average of 5.3. In 2024, the Croatian Ministry of Health ordered 12 Elekta linear accelerators and four brachytherapy systems in an effort to close that gap.

By taking over its distributor’s operations and increasing its footprint in the country, Elekta aims to provide faster service delivery and long-term technical support for those systems.

The company employs roughly 4,500 people globally and is active in more than 40 countries.

European News Homepage